“Circulating Tumour DNA for Minimal Residual Disease: Assay Sensitivity and the Decisions It Cannot Yet Support” (2023) Translational Medicine & Therapeutics Journal, 2(2), pp. 110–119. doi:10.5281/zenodo.22649122.